Potential glucose sensor for perioperative blood glucose control in diabetes mellitus
β Scribed by Katherine R. Greenough; Andrew W. Skillen; Calum J. McNeil
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 506 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0956-5663
No coin nor oath required. For personal study only.
β¦ Synopsis
A glucose sensor intended for future use in diabetic patients undergoing major surgery is described. It involves glucose oxidase immobilised at a platinised activated carbon electrode (PACE). The sensor gave a nonoxygen dependent amperometric response in whole undiluted blood and did not require the use of electron mediators. In vitro studies in protein containing buffer using a flow cell indicated current densities of approximately 160 nA mrne2 mM-' and a linear response over the range O-20 mM. The operational stability of the sensor was at least 49 h in continuous use. In addition the sensor had a 90-99% response time of 1 min when used at a flow rate of 3 ml min-' and showed a temperature dependence of 2.4% C-l. The results reported suggest significant advantages of this approach, for future use as a perioperative intra-vascular sensor for diabetic subjects, over previously reported glucose sensors.
π SIMILAR VOLUMES
## Abstract We wished to examine the effect of free provision of miniaturised glucose sensors on glycaemic control in our children's diabetes clinic. Thirtyβsix children were studied over six months. Those already using meters formed a control group (n=11). The remainder were randomised according t
A potentially wearable glucose sensor was developed, consisting of an oxygen electrode as detector and a dynamic enzyme perfusion system as selector. The selector is a hollow fibre, which can be placed subcutaneously and dialyses glucose from tissue fluid. In this design the problems of enzyme insta
## Abstract Home blood glucose monitoring (HBGM), if performed correctly, is potentially the most satisfactory way of monitoring diabetic control. This study describes the prevalence, pattern and performance of HBGM in 171 children, aged 10β16 years, with insulinβdependent diabetes mellitus (IDDM).